Minot Light Capital Partners, an investment management company, released its “Capital Appreciation Fund” Q1 2026 Investor Letter. A copy of the letter can be downloaded here. The fund declined by 2.7% in the first quarter of 2026 due to a sharp macro-driven sector rotation following geopolitical tensions, which triggered inflation fears and rising interest rate expectations. This scenario led to a shift in investor focus toward sectors such as energy, defense, and AI-linked stocks, while the fund’s core exposure to healthcare, consumer, and idiosyncratic industrials lagged. Despite this setback, the firm maintains a constructive long-term outlook, suggesting that the current market volatility and consensus-driven market narratives are creating attractive opportunities in out-of-favor sectors where it continues to find compelling valuations and expects eventual mean reversion to drive future returns. In addition, you can check the Fund’s top five holdings to determine its best picks for 2026.
In its first-quarter 2026 investor letter, Minot Light Capital Appreciation Fund highlighted stocks like NeurAxis, Inc. (NYSEAMERICAN:NRXS). NeurAxis, Inc. (NYSEAMERICAN:NRXS) is a medical technology company developing neuromodulation therapies for chronic and functional disorders. The one-month return of NeurAxis, Inc. (NYSEAMERICAN:NRXS) was 12.43% while its shares traded between $2.07 and $9.33 over the last 52 weeks. On May 15, 2026, NeurAxis, Inc. (NYSEAMERICAN:NRXS) stock closed at approximately $7.87 per share, with a market capitalization of about $97.46 million.
Minot Light Capital Appreciation Fund stated the following regarding NeurAxis, Inc. (NYSEAMERICAN:NRXS) in its Q1 2026 investor letter:
“In general, our top five contributors to the portfolio this quarter represent a nice mix of emerging growth, core growth, and deep value holdings. NeurAxis, Inc. (NYSEAMERICAN:NRXS) is one of them. Neuraxis (NRXS), an emerging growth medical device company at the earliest stages of commercialization that is currently benefitting from recent inclusion into industry guidelines and reimbursement progress.
create jobs 51/Shutterstock.com
NeurAxis, Inc. (NYSEAMERICAN:NRXS) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. As per our database, 2 hedge fund portfolios held NeurAxis, Inc. (NYSEAMERICAN:NRXS) at the end of the fourth quarter, which was 2 in the previous quarter. While we acknowledge the risk and potential of NeurAxis, Inc. (NYSEAMERICAN:NRXS) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NeurAxis, Inc. (NYSEAMERICAN:NRXS) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In another article, we covered NeurAxis, Inc. (NYSEAMERICAN:NRXS) and shared the company’s earnings call transcript. In addition, please check out our hedge fund investor letters Q1 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years
Disclosure: None. This article is originally published at Insider Monkey.
